Cardiogenic Shock Articles & Analysis
5 news found
This investment will further refine our technology platform that aims to minimize vascular complications and improve outcomes for high-risk PCI and cardiogenic shock patients,” commented Dr. Nitin Salunke, President and CEO of Supira Medical. ...
In a pilot study of 24 pediatric patients requiring postcardiotomy extracorporeal membrane oxygenation (ECMO) for severe refractory cardiogenic shock after ischemia reperfusion injury, 10 were treated with intramyocardial autologous mitochondrial transplantation. ...
In 2011, Ivo Simundic joined Xenios AG where he co-invented, co-developed and obtained the CE marking for the i-cor® project – the first synchronized pulsatile cardiac assist for interventional cardiology to treat cardiogenic shock and to protect cath-lab interventions. Following the acquisition of Xenios AG by Fresenius Medical Care in 2016, he became ...
ByCarmat
Additionally, pVADs are used to treat patients suffering from cardiogenic shock (CS), a condition that can occur following a severe heart attack, and is associated with a high rate of morbidity as a patient’s heart is suddenly too weak to adequately pump blood to vital organs. ...
While we were working, we determined it would be a shorter regulatory path to have a catheter temporary aortic stent pump which could relieve the patient of excess fluids, help them get through a high risk Percutaneous Coronary intervention (PCI) procedure, maybe help them recover from cardiogenic shock and, most needed to help patients recover from cardio-renal ...